Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141999 · ClinicalTrials.gov registry record
Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
A clinical trial, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- 400
- Enrollment target
NCT00141999 is a clinical trial that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 400 participants.
The verdict
NCT00141999 has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the immune response to an additional (booster) dose of hepatitis B vaccine 5-14 years after a three dose series was given
Interventions
- BIOLOGICAL hepatitis B vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2001-05 |
| Est. Completion | 2008-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00141999
The ClinicalTrials.gov registry entry for NCT00141999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hepatitis B vaccine is the first listed.
NCT00141999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00141999 about?
NCT00141999 is a clinical study titled "Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents". The purpose of this study is to determine the immune response to an additional (booster) dose of hepatitis B vaccine 5-14 years after a three dose series was given
What is the current status of trial NCT00141999?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2001-05. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00141999?
The interventions under investigation include: hepatitis B vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00141999?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.